CompletedNot Applicable

Dynamic Taping in Symptomatic Rotator Cuff Tendinopathy

Turkey (Türkiye)60 participantsStarted 2021-03-01

Plain-language summary

This study was conducted to compare the efficacy of two different therapeutic bands in symptomatic rotator cuff tendinopathy. One of the tapes was kinesio tape and the other was dynamic tape. The study was in a parallel group randomized controlled trial design.

Who can participate

Age range

18 Years – 65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Those with a diagnosis of RCT * Those with subacromial pain * At least two of the three impingement tests are positive (empty-can test, Hawkins-Kennedy test, modified Neer test) * 18-65 years old Exclusion Criteria: * Those with open wounds at the taping area * Those who have allergic reactions to taping * Those who have had shoulder surgery before * Those with total rotator cuff tendon rupture * Those with a history of fractures in the upper extremity or glenohumeral joint subluxation -- Presence of adhesive capsulitis (those with more than passive shoulder joint motion loss 70%) * Presence of congenital or acquired deformity involving the upper extremity * Those with rheumatic or neurologic disease * Those with cervical radiculopathy * Those with a history of neoplasm or cognitive impairment (MMSE\<24) * Those who received corticosteroid injection to the shoulder region in the last 3 months * Those who received physiotherapy treatment in the last 3 months

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Acromiohumeral Distance (AHD)

Timeframe: Change in acromiohumeral distance at 6 week

Trial details

NCT IDNCT05029544

SponsorMuğla Sıtkı Koçman University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-06-12

View on ClinicalTrials.gov More Rotator Cuff Tendinosis trials

Who can participate

Age range

18 Years – 65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.